Why is Apogee Therapeutics, Inc. stock up today?
August 7, 2026
Apogee Therapeutics, Inc.
APGE · NGM · USD
vs. prev. close $134.23
Last updated Aug 6, 2026 20:00
Intraday Chart — 5-min intervals
APGE · less than a minute ago
Apogee Therapeutics, Inc. edges higher 0.19% — Insider Monkey reports
Apogee Therapeutics, Inc. (APGE) is holding steady with a slight gain, at $134. 49 — up 0. 19% from yesterday's close of $134. 23. Today's move appears driven by recent headlines, including "Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout" and "Sector Update: Healthcare Stocks Softer Late Afternoon". News sentiment around APGE is leaning positive.
The broader market is under pressure (S&P 500: -0. 2%, Nasdaq: -0. 1%, Dow Jones: -0. 9%, Shanghai: +1. 3%, Hang Seng: +0. 3%). Past performance does not guarantee future results.
Key Factors
Auto-generated analysis · Not financial advice
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout
Insider Monkey·2 days agoneutralSector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires·2 days agoneutralSector Update: Healthcare
MT Newswires·2 days agoneutralMarket Chatter: AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition
MT Newswires·3 days agoneutralMerck, Pfizer Lift Full-Year Sales Outlooks Following Second-Quarter Beats
MT Newswires·3 days agopositiveIs Apogee Therapeutics (APGE) Fully Priced, Or Still A Bargain?
Simply Wall St.·3 days agoneutralABBV Q2 Earnings Call Balances Growth With Apogee Dilution
Zacks·4 days agoneutralAbbVie Quietly Solved Its Biggest Problem—Now What?
MarketBeat·5 days agoneutral
S&P 500
-0.18%
Nasdaq
-0.06%
Dow Jones
-0.85%
Shanghai
+1.34%
Hang Seng
+0.31%
Nikkei 225
-0.21%
FTSE 100
-0.19%
Nifty 50
-0.33%
DAX
+0.05%
OMX Stockholm
-0.12%
Search another stock